Gattex will bring in 500 mill in revenue, Natpara will brting in another 500 mill. This company is setting the stage for a billion dollar revenue stream and is a triple from here, easily. They are projeccting to be profitable in 2014. NPS has six partnered drugs in the market, with two on their way, and yet another two or three still in development on their R&D pipeline. With 17% short, this is a long's dream stock.